// App-Quantinova.ai

e15100 : PD-1 inhibition in cutaneous squamous cell carcinoma (cSCC).

Researchers

Presenter

  • David Jacob Hermel

Principal Investigators

  • Omar Medhat Ragab

  • Shauna Higgins

  • Ashley Wysong

  • Gino Kim In

Medical Centers

  • Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • Department of Radiation Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim